These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2791870)

  • 1. [The effect of intensification of an HIV viral infection with monoclonal antibodies].
    Ignat'eva GA; Sidorovich IG; Nesterchuk SL; Barinskiĭ IF
    Dokl Akad Nauk SSSR; 1989; 306(5):1272-5. PubMed ID: 2791870
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of CD4 in HIV infection and therapy.
    Amantea MA
    Am J Hosp Pharm; 1991 Jun; 48(6):1300. PubMed ID: 1677530
    [No Abstract]   [Full Text] [Related]  

  • 3. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
    J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of CD28 costimulation on HIV production by CD4+ cells.
    Barker E; Bossart KN; Levy JA
    J Immunol; 1998 Dec; 161(11):6223-7. PubMed ID: 9834109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection.
    Robinson JE; Elliott DH; Martin EA; Micken K; Rosenberg ES
    Hum Antibodies; 2005; 14(3-4):115-21. PubMed ID: 16720981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
    Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
    AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.
    Pruenster M; Wilflingseder D; Bánki Z; Ammann CG; Muellauer B; Meyer M; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2005 Sep; 35(9):2691-8. PubMed ID: 16094691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic immunophenotyping artefact seen in patients with anti-mouse immunoglobulin antibodies.
    Wilks D; Byrom N; Walker L; Habeshaw J; Dalgleish A
    Cytometry; 1990; 11(2):318-9. PubMed ID: 2318086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
    Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
    J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
    Roth MD; Tashkin DP; Whittaker KM; Choi R; Baldwin GC
    Life Sci; 2005 Aug; 77(14):1711-22. PubMed ID: 15964028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity.
    Asin SN; Wildt-Perinic D; Mason SI; Howell AL; Wira CR; Fanger MW
    J Infect Dis; 2003 May; 187(10):1522-33. PubMed ID: 12721932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV infection].
    Cordero GC
    Sidahora; 1995; ():10-2. PubMed ID: 11363196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency.
    Ffrench R; Stewart GJ; Penny R; Levy JA
    Med J Aust; 1996 Feb; 164(3):166-71. PubMed ID: 8628137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p56lck-negative HTLV-I-transformed cell line.
    Lemasson I; Briant L; Hague B; Coudronnière N; Heron L; David C; Rebouissou C; Kindt T; Devaux C
    J Immunol; 1996 Jan; 156(2):859-65. PubMed ID: 8543843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis.
    Guillerm C; Robert-Hebmann V; Hibner U; Hirn M; Devaux C
    Virology; 1998 Sep; 248(2):254-63. PubMed ID: 9721234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
    Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
    Cohen J
    Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.